"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

Clinical trial NCT00056407 · COMPLETED

Trial details

NCT number: NCT00056407
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Prostate

Start date: 2003-03-01
Primary completion: 2009-01-01
Enrollment: 8231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.